$CARM

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Carisma Therapeutics Inc. (Nasdaq - CARM), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC), Turnstone Biologics Corp. (Nasdaq - TSBX)

BALA CYNWYD, Pa., June 27, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.

Original reporting
Benzinga · Globe Newswire
Published Jun 27, 2025, 3:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 27, 2025, 4:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CARM
Neutral
high confidence
Mentioned
$CARM
AlphAI data visualization · based on Benzinga
Decision brief

The 30-second read

$CARMNeutralMed
01

Why it matters

The investigations introduce uncertainty, potentially leading to increased volatility, especially for the more relevant tickers.

02

Market read

The news has moderate to low relevance for most tickers, with GBCI and MRC being more impacted due to their higher relevance scores and bullish sentiment.

03

What to watch

Potential for positive resolution or dismissals that could lead to short-term rebounds; also, broader market conditions may overshadow company-specific news.

Timing: Immediate to short-term (next 1-2 trading sessions)

Background

The news pertains to investigations involving multiple companies, which could influence investor sentiment and stock prices.

Company-level read

Ticker impact

$CARMNeutralHigh confidence
Context

Low relevance; neutral sentiment and minimal impact due to its low relevance score.

Expected impact

Expected negligible movement, less than 1%.

Evidence & confidence

The low relevance score and neutral sentiment suggest limited immediate trading impact.

Market effects

Potential impact on Life Sciences, Financial Markets, and Mergers & Acquisitions sectors due to ongoing investigations.

Limited regional impact; primarily affecting US-based companies.

Low; investigation news is company-specific and unlikely to influence global markets significantly.

Counterpoint

Investigations may lead to negative sentiment and potential declines if allegations are substantiated, suggesting caution in bullish assumptions.

Key entities

  • Brodsky & Smith

    Legal firm providing shareholder updates and investigation notices.

  • Carisma Therapeutics Inc.

    Subject of investigation, listed on Nasdaq (CARM).

  • Guaranty Bancshares, Inc.

    Subject of investigation, listed on NYSE (GNTY).

  • MRC Global Inc.

    Subject of investigation, listed on NYSE (MRC).

  • Turnstone Biologics Corp.

    Subject of investigation, listed on Nasdaq (TSBX).

Related articles

$AMZNMed

Amazon (AMZN) Pauses a Cargo Carrier after a Fatal Crash. Can its Air Network Absorb the Disruption?

Amazon (AMZN) paused operations with 21 Air after a fatal cargo plane crash. The company cited support for the investigation and review of circumstances. Amazon reported $27.5B operating income and $200.6B revenue in Q2 2026, indicating financial capacity to absorb disruptions. This is the second fatal crash involving an Amazon-contracted aircraft in seven years, raising scrutiny of its logistics partner oversight.

$TSLAHighAI 8/10

Tesla Scores Deal To Help Double The US Electric Semi-Truck Fleet

Tesla announced it will start delivering its electric semi-truck in September 2026, aiming to produce 50,000 units annually. The company secured an order for 2,500 trucks from the ZET SCALE alliance, including Microsoft and PepsiCo. Tesla plans to deploy these trucks in major freight hubs. The Semi will have two range options: 350 miles (Standard Range) and 500 miles (Long Range).

$CVXHigh

HSBC sets new Chevron price target amid Iran tensions

HSBC raised its price target for Chevron (CVX) to $250 from $218, citing strong cash flow forecasts and low Middle East exposure. The stock, currently at $204, has gained 31% year-to-date but has fallen from its September peak. HSBC also noted Chevron's profit sensitivity to oil prices and its disciplined investment approach.

$LMTHighAI 9/10

Lockheed Martin (LMT) Gets Another Boost from the Long-Range Missile Push

Lockheed Martin (LMT) won a $1.2B U.S. Army contract for its Precision Strike Missile (PrSM) Increment 2. The company's Missiles and Fire Control segment saw Q2 2026 sales rise 19% YoY to $4.1B, with $175M in incremental sales from PrSM and other tactical missiles. The contract adds to a backlog of $87.9B, but execution risks include capacity and supply chain pressures.